Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.420
+0.100 (3.01%)
May 19, 2025, 12:44 PM - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $36.88 million as of May 19, 2025. Its market cap has decreased by -36.40% in one year.
Market Cap
36.88M
Enterprise Value
14.98M
1-Year Change
-36.40%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $36.88M, an increase of 21.61%. That is a compound annual growth rate of 4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 35.81M | 4.08% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |